Łukasz Szczerbiński
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
-
- Adipose Tissue and Metabolism 6
- Diet and metabolism studies 4
-
- Liver Disease Diagnosis and Treatment 8
-
- Genetic Associations and Epidemiology 6
-
- Bariatric Surgery and Outcomes 6
- Pancreatic function and diabetes 4
-
- Metabolomics and Mass Spectrometry Studies 5
- Co-authors
- Adam KrętowskiJosé C. FlorezAleksandra GolonkoPaweł SowaW. LewandowskiAnna Moniuszko‐MalinowskaRenata ŚwisłockaHady Razak Hady
- Partner nations
- PolandUnited StatesDenmark
In The Last Decade
Łukasz Szczerbiński
42 papers receiving 496 citations
Peers
Comparison fields: 5 of 88
- Health 41
- Cancer Research 68
- Endocrinology, Diabetes and Metabolism 73
- Physiology 109
- Biological Psychiatry 9
Countries citing papers authored by Łukasz Szczerbiński
This map shows the geographic impact of Łukasz Szczerbiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Łukasz Szczerbiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Łukasz Szczerbiński more than expected).
Fields of papers citing papers by Łukasz Szczerbiński
This network shows the impact of papers produced by Łukasz Szczerbiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Łukasz Szczerbiński. The network helps show where Łukasz Szczerbiński may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Łukasz Szczerbiński, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 39 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 37 | |
| 8 | 2024 | 0 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 48 | |
| 17 | 2021 | 7 | |
| 18 | 2020 | 13 | |
| 19 | 2019 | 26 | |
| 20 | 2014 | 8 |
About Łukasz Szczerbiński
Łukasz Szczerbiński is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacy and Physiology, having authored 45 papers that have together received 505 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (8 papers), Genetic Associations and Epidemiology (6 papers), Bariatric Surgery and Outcomes (6 papers), Adipose Tissue and Metabolism (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Diet and metabolism studies (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers) and Pancreatic function and diabetes (4 papers). The work is most often cited by research in Health (41 citations), Cancer Research (68 citations) and Endocrinology, Diabetes and Metabolism (73 citations). Łukasz Szczerbiński has collaborated with scholars based in Poland, United States and Denmark. Frequent co-authors include Adam Krętowski, José C. Florez, Aleksandra Golonko, Paweł Sowa, W. Lewandowski, Anna Moniuszko‐Malinowska, Renata Świsłocka, Hady Razak Hady, Maria Górska and Karol Kamiński. Their work appears in journals such as Nature Medicine, Diabetes and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.